AdipoPhYt
Rennes
About AdipoPhYt
Since its creation in 2010, AdipoPhYt is based on the founding principle that adipose tissue biology is central to weight management and metabolic diseases. Using specific skills, knowledge and proprietary technology, AdipoPhYt has developed a range of ex vivo adipose tissue products & services in order to improve clinical decision making and translational medicine. The Company business is concentrated on ex vivo based assays for use in drug discovery, nutrition and cosmetic research. Discovery programs are conducted either in partnership or by AdipoPhYt R&D. AdipoPhYt Company staff, recruited from both industrial science and academic research, forms an experienced team, equally familiar with quality assurance, project milestones and customer support as with research and technological innovation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Last round: Series Unknown (Jan 2010)
- Website: adipophyt.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/adipophyt-3140511 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.